CME Group Inc. (NASDAQ:CME) insider Hilda Harris Piell sold 1,350 shares of the company’s stock in a transaction that occurred on Thursday, October 5th. The shares were sold at an average price of $138.00, for a total value of $186,300.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Hilda Harris Piell also recently made the following trade(s):
- On Wednesday, September 6th, Hilda Harris Piell sold 714 shares of CME Group stock. The shares were sold at an average price of $129.00, for a total value of $92,106.00.
Shares of CME Group Inc. (NASDAQ CME) opened at 137.71 on Friday. The stock has a market capitalization of $46.81 billion, a price-to-earnings ratio of 28.11 and a beta of 0.73. CME Group Inc. has a 1-year low of $98.95 and a 1-year high of $138.49. The stock has a 50 day moving average price of $131.99 and a 200 day moving average price of $123.73.
CME Group (NASDAQ:CME) last posted its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.03. The company had revenue of $925.00 million during the quarter, compared to the consensus estimate of $931.05 million. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The firm’s quarterly revenue was up 2.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.14 earnings per share. Equities research analysts anticipate that CME Group Inc. will post $4.81 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, September 25th. Shareholders of record on Friday, September 8th were given a $0.66 dividend. The ex-dividend date was Thursday, September 7th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 1.92%. CME Group’s dividend payout ratio (DPR) is currently 53.99%.
Several research firms have recently weighed in on CME. Barclays PLC increased their price target on CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a report on Tuesday. Wells Fargo & Company increased their price target on CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a report on Wednesday, October 4th. BidaskClub raised CME Group from a “buy” rating to a “strong-buy” rating in a report on Wednesday, September 27th. Keefe, Bruyette & Woods reissued a “hold” rating and set a $133.00 price target on shares of CME Group in a report on Thursday, September 21st. Finally, UBS AG reissued a “buy” rating and set a $135.00 price target (up from $134.00) on shares of CME Group in a report on Wednesday, September 6th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $135.89.
Several institutional investors have recently modified their holdings of the business. Crow Point Partners LLC raised its position in shares of CME Group by 9.6% in the third quarter. Crow Point Partners LLC now owns 5,909 shares of the financial services provider’s stock worth $803,000 after acquiring an additional 519 shares during the period. Intl Fcstone Inc. acquired a new position in shares of CME Group in the second quarter worth about $1,176,000. Toronto Dominion Bank raised its position in shares of CME Group by 23.5% in the second quarter. Toronto Dominion Bank now owns 129,458 shares of the financial services provider’s stock worth $16,214,000 after acquiring an additional 24,592 shares during the period. Cetera Investment Advisers acquired a new position in shares of CME Group in the second quarter worth about $242,000. Finally, Advisory Services Network LLC raised its position in shares of CME Group by 8,266.3% in the second quarter. Advisory Services Network LLC now owns 6,944 shares of the financial services provider’s stock worth $870,000 after acquiring an additional 6,861 shares during the period. Institutional investors and hedge funds own 82.64% of the company’s stock.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
What are top analysts saying about CME Group Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CME Group Inc. and related companies.